Syros Pharmaceuticals Announces Publication Of Important Scientific Studies Related To Company's Industry-Leading Gene Control Platform
Published: Dec 18, 2013
WATERTOWN, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals, a life sciences company harnessing breakthroughs in gene control to revolutionize the treatment of cancer and other diseases, announced today that papers recently published by Syros Scientific Founders Richard A. Young, Ph.D., and James E. Bradner, M.D., in Cancer Cell and Nature Biotechnology provide further validation of the Syros scientific platform.
Help employers find you! Check out all the jobs and post your resume.